Samsara BioCapital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Samsara BioCapital’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-202,773	Closed	-$9.42M	–	49
2023 Q2	$9.42M	Hold	202,773	–	–	1.65%	12
2023 Q1	$5.81M	Hold	202,773	–	–	1.2%	18
2022 Q4	$6.33M	Sell	202,773 -50,693	-20%	-$1.65M	1.36%	17
2022 Q3	$5.14M	Hold	253,466	–	–	1.2%	21
2022 Q2	$3.93M	Buy	253,466 +25,000	+11%	+$430K	1.05%	23
2022 Q1	$4.37M	Buy	+228,466	New	+$4.08M	1.1%	25

Samsara BioCapital's DICE Position: Q3 2023 in Review

Samsara BioCapital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 202,773 shares — an estimated $9.42M sold.

Samsara BioCapital first reported a position in DICE in Q1 2022 and held it in 6 quarters. The position peaked at $9.42M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Samsara BioCapital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Samsara BioCapital sold 202,773 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.42M.
Samsara BioCapital first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Samsara BioCapital's DICE Therapeutics, Inc. Common Stock position peaked at $9.42M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Samsara BioCapital's 13F filing for Q3 2023, filed 14 Nov 2023.